Gene · 3459
Papers3,929
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,929
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications. | Front Immunol | 2023 | 37767098 | PubTator, text mining | PubMed |
| Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report. | Pathogens | 2023 | 37764964 | PubTator, text mining | PubMed |
| Potential of Dietary HDAC2i in Breast Cancer Patients Receiving PD-1/PD-L1 Inhibitors. | Nutrients | 2023 | 37764768 | PubTator, text mining | PubMed |
| Interferons-Implications in the Immune Response to Respiratory Viruses. | Microorganisms | 2023 | 37764023 | PubTator, text mining | PubMed |
| Disseminated Mycobacterium genavense Infection Mimicking Sarcoidosis: A Case Report and Review of Literature on Japanese Patients. | Microorganisms | 2023 | 37763989 | PubTator, text mining | PubMed |
| Advances in Targeted Therapy for the Treatment of Cervical Cancer. | J Clin Med | 2023 | 37762931 | PubTator, text mining | PubMed |
| Defining the Basal and Immunomodulatory Mediator-Induced Phosphoprotein Signature in Pediatric B Cell Acute Lymphoblastic Leukemia (B-ALL) Diagnostic Samples. | Int J Mol Sci | 2023 | 37762241 | PubTator, text mining | PubMed |
| Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications. | Int J Mol Sci | 2023 | 37762066 | PubTator, text mining | PubMed |
| Pyroptosis and inflammasomes in cancer and inflammation. | MedComm (2020) | 2023 | 37752941 | PubTator, text mining | PubMed |
| Blockade of interferon signaling decreases gut barrier integrity and promotes severe West Nile virus disease. | Nat Commun | 2023 | 37749080 | PubTator, text mining | PubMed |
| Disseminated Mycobacterium fortuitum infection in a young girl with IFN-γR1 defect masquerading as histiocytosis. | Pediatr Allergy Immunol | 2023 | 37747748 | PubTator, text mining | PubMed |
| Herring roe oil in treatment of psoriasis - influence on immune cells and cytokine network. | Front Immunol | 2023 | 37744329 | PubTator, text mining | PubMed |
| Phosphoflow cytometry to assess cytokine signaling pathways in peripheral immune cells: potential for inferring immune cell function and treatment response in patients with solid tumors. | J Exp Clin Cancer Res | 2023 | 37741983 | PubTator, text mining | PubMed |
| Transcriptomic analysis of stem cells from chorionic villi uncovers the impact of chromosomes 2, 6 and 22 in the clinical manifestations of Down syndrome. | Stem Cell Res Ther | 2023 | 37740230 | PubTator, text mining | PubMed |
| Identification of memory B-cell-associated miRNA signature to establish a prognostic model in gastric adenocarcinoma. | J Transl Med | 2023 | 37735667 | PubTator, text mining | PubMed |
| Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen-specific tumor cell killing by cytotoxic T cells. | Elife | 2023 | 37732732 | PubTator, text mining | PubMed |
| Disseminated Nontuberculous Mycobacterial Infection in a Tertiary Referral Hospital in South Korea: A Retrospective Observational Study. | Yonsei Med J | 2023 | 37727920 | PubTator, text mining | PubMed |
| Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss. | BMC Med | 2023 | 37726769 | PubTator, text mining | PubMed |
| Therapeutic Effects of Upadacitinib on Experimental Autoimmune Uveitis: Insights From Single-Cell Analysis. | Invest Ophthalmol Vis Sci | 2023 | 37713206 | PubTator, text mining | PubMed |
| Signaling pathways in macrophages: molecular mechanisms and therapeutic targets. | MedComm (2020) | 2023 | 37706196 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3459/papers?page=16